Form 4 for GRAL GRAIL, Inc.
Accepted 2026-09-23 16:37:03 ET · period of report 2026-09-21 · accession 0001628280-26-063233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-23 16:37 | 2026-09-21 | GRAL | Ofman Joshua J. | CEO, Dir | M - OptEx | $14.00 | +26.5K | 423.7K | +7% | +$370.3K |
| DMT | 2026-09-23 16:37 | 2026-09-21 | GRAL | Ofman Joshua J. | CEO, Dir | S - Sale+OE | $97.74 | -61.5K | 362.3K | -15% | -$6.01M |
| DT | 2026-09-23 16:37 | 2026-09-21 | GRAL | Ofman Joshua J. | CEO, Dir | M - OptEx | $0.00 | -26.5K | 37.0K | -42% | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-21 | M | A | 26,452 | $14.00 | 423,723 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-21 | S | D | 2,125 | $92.32 | 421,598 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.04 to $92.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 3 | Common | Common Stock | 2026-09-21 | S | D | 1,454 | $93.61 | 420,144 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.04 to $93.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 4 | Common | Common Stock | 2026-09-21 | S | D | 37,752 | $94.98 | 382,392 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.5 to $95.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 5 | Common | Common Stock | 2026-09-21 | S | D | 6,200 | $96.43 | 376,192 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.00 to $96.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 6 | Common | Common Stock | 2026-09-21 | S | D | 1,400 | $97.84 | 374,792 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.74 to $98.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 7 | Common | Common Stock | 2026-09-21 | S | D | 421 | $99.85 | 374,371 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.42 to $100.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 8 | Common | Common Stock | 2026-09-21 | S | D | 2,100 | $100.68 | 372,271 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.68 to $100.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 9 | Common | Common Stock | 2026-09-21 | S | D | 10,000 | $110.00 | 362,271 | D | — | — | (F1) The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025 |
| 10 | Derivative | Stock Option | 2026-09-21 | M | D | 26,452 | $0.00 | 37,032 | D | $14.00 · — to 2030-03-05 | 26,452 Common Stock | (F9) Represents an option originally granted on March 6, 2020 for which the performance condition was determined to be met on November 1, 2024. The option vests and becomes exercisable in thirty-six substantially equal monthly installments beginning December 1, 2024. As of September 21, 2026, approximately 61% of the shares subject to the option had vested, and the remaining approximately 39% of the shares vests over the remaining period afterwards. |